What the ESCRS meta-analysis found
The review examined data from millions of participants, mainly from East Asia and the United Kingdom. Researchers compared measured levels of PM2.5, PM10, nitrogen dioxide, sulphur dioxide, ozone and carbon monoxide with recorded diagnoses of glaucoma, cataract and age-related macular degeneration. The strongest and most consistent signal appeared for PM2.5 and glaucoma.
People living in the most polluted areas showed up to 70% higher odds of glaucoma compared with those in the least polluted areas. A dose-response relationship was also observed for cataract: risk rose steadily as pollution levels increased. The analysis drew on some of the world’s largest eye-health databases, allowing researchers to detect patterns that smaller studies had missed. Because the data spanned multiple countries and large populations, the associations held after accounting for age and other known risk factors. The presentation at the ESCRS congress highlighted that the link was clearest for the smallest particles, which can penetrate deeper into the body. No single pollutant other than PM2.5 produced equally consistent results across the 41 studies, and the researchers noted that the observational design leaves room for residual confounding even after statistical adjustment. The systematic approach combined findings from diverse populations and confirmed that the risk elevation for glaucoma remained significant even when other variables were controlled. This breadth of evidence strengthens the conclusion that air pollution contributes to eye disease beyond previously recognised factors.
Scale of the two eye conditions
According to Dr Filomena Ribeir, former ESCRS president, cataract remains the leading cause of vision loss worldwide and affects roughly 94 million people. Glaucoma damages the optic nerve and can cause irreversible sight loss if untreated; it affects approximately 7.7 million people globally. Both conditions become more common with age, yet the new evidence indicates that environmental exposure can accelerate their onset.
In the European Union, more than 5 million cataract operations were performed in 2023, equivalent to 1,118 procedures per 100,000 inhabitants. Greece recorded about 99,000 operations the same year. The Thessaloniki Eye Study found glaucoma prevalence of 5.5% among people over 60, translating to an estimated 170,000 affected individuals in that age group. In Greece, seven out of ten citizens aged 75 and older show lens clouding consistent with cataract. These figures illustrate the existing burden on health systems; any additional risk factor that can be modified therefore carries practical importance for planning future services. The source provides no projection of how many additional cases might be prevented by lower pollution, leaving that quantification open for future modelling. The large number of procedures already performed each year in Greece and across the EU underscores how even small shifts in incidence could translate into meaningful differences in surgical demand and patient outcomes over time.
Expert commentary on mechanisms and implications
Dr Ahmed Alnabihi of the King Khaled Eye Specialist Hospital noted that while air pollution has long been known to harm lungs and heart, its effects on the eyes have received far less attention. He emphasised that recognising an environmental accelerator for age-related eye disease opens the possibility of preventive interventions at population level.
Dr Ribeir added that the findings change clinical thinking: conditions once viewed purely as age-related may also be influenced by modifiable external factors. Improved air quality could therefore become an additional public-health lever for protecting vision. The researchers stressed that glaucoma and cataract are often described as age-related, yet the presence of a measurable environmental contributor alters prevention strategies. Public-health measures that lower PM2.5 could reduce the number of people who develop these conditions earlier than expected, easing both individual suffering and healthcare costs. The source contains no detailed biological pathway explaining how particles reach ocular tissues, so the precise mechanism remains unstated. The expert statements highlight that the study reframes these diseases as partly preventable through environmental action rather than inevitable consequences of ageing alone.
Relevance for Greece and the wider region
Greece experiences seasonal spikes in PM2.5 from traffic, heating and regional dust events. With an ageing population and already high cataract surgery volumes, even modest risk reductions from cleaner air would affect thousands of future cases. The study authors call for greater inclusion of eye-health outcomes in air-quality policy evaluations. National data already show that glaucoma prevalence rises sharply after age 60, reaching 5.5 percent in the Thessaloniki Eye Study cohort. Adding air pollution as a contributing factor means that policies aimed at reducing emissions could have measurable benefits for eye health alongside respiratory and cardiovascular gains. The ESCRS presentation therefore urged ophthalmologists and policymakers to consider vision outcomes when setting air-quality targets. The source does not report current Greek PM2.5 levels or quantify the expected reduction in eye disease if standards were tightened. The combination of high existing prevalence and ongoing pollution exposure positions Greece as a setting where integrated health and environmental policies could yield visible benefits for eye care services.
Frequently asked questions
Which pollutant showed the clearest link to glaucoma?
PM2.5 fine particles produced the strongest and most consistent association across the 41 studies included in the meta-analysis.
How large is the risk increase?
Residents of the most polluted areas had up to 70% higher odds of glaucoma compared with residents of the least polluted areas.
Does the same pattern apply to cataract?
Yes. Risk of cataract rose steadily with increasing pollution levels, although the percentage increase was smaller than for glaucoma.
Where did most of the data come from?
The largest cohorts originated in East Asia and the United Kingdom, covering several of the world’s biggest eye-health databases.
What does this mean for public health?
Eye health now joins cardiovascular and respiratory outcomes as a reason to treat air-quality improvement as a medical priority rather than solely an environmental one.
